Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Neoplasms 3Radiation Injuries 1Prostatic Neoplasms 1Neoplasms, Second Primary 1Lung Neoplasms 1Head and Neck Neoplasms 1Eye Diseases 1Colorectal Neoplasms 1Cognitive Dysfunction 1Cardiovascular Diseases 1

Interventions

Temozolomide 2Radiosurgery 2Leucovorin 2Irinotecan 2Fluorouracil 2sacubitril and valsartan sodium hydrate drug combination 1icotinib 1dostarlimab 1beta Carotene 1avelumab 1alpha-Tocopherol 1Varenicline 1Tobacco Use Cessation Devices 1Therapeutics 1Thalidomide 1Radiotherapy 1Probiotics 1Panitumumab 1Nicotine Chewing Gum 1Myofascial Release Therapy 1Megestrol Acetate 1Isotretinoin 1Folfox protocol 1Drug Therapy 1Doxycycline 1Docetaxel 1Cryosurgery 1Clonidine 1Cetuximab 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neoplasms, Second Primary × beta Carotene × Clear all
NCT00169845 2018-03-14

Beta-carotene and Alpha-tocopherol Chemoprevention of Second Primary Malignancies in Head and Neck Cancer Patients

Laval University

Phase 3 Completed
540 enrolled
Head & Neck

Head and Neck Neoplasms, Neoplasms, Radiation Injuries, Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡